Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway

Han X, Yang Y, Zhang M, Li L, Xue Y, Jia Q, Wang X, Guan S

Drug Design, Development and Therapy 2022, 16:4111-4125

Published Date: 2 December 2022